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The objective of this study was to evaluate the construct validity of two questionnaire-based measures of health-related quality of life
(HRQL) in children undergoing cancer chemotherapy: the Health Utilities Index (HUI) and the Child Health Questionnaire (CHQ).
Subjects were children hospitalised for chemotherapy. To examine construct validity: (1) a priori expected relations between CHQ
concepts and HUI attributes were examined; (2) HUI and CHQ summary scores were compared to visual analogue scale (VAS)
scores. Ease of completion was rated using a 5-point categorical scale and completion time was recorded. A total of 36 subjects were
included. The maximum score was seen in 15 (47%) of HUI3 assessments. As predicted, CHQ body pain was moderately correlated
with HUI3 pain (r¼0.51), CHQ physical functioning was moderately correlated with HUI2 mobility (r¼0.58) and CHQ mental
health was moderately correlated with HUI2 emotion (r¼0.53). Only the CHQ psychosocial subscale (and not HUI) was correlated
with VAS (r¼0.44). The CHQ and the HUI were both easy to use. The HUI questionnaires required less time to complete
(mean¼3.1, s.d.¼1min) compared with CHQ (mean¼13.1, s.d.¼3.4min, Po0.0001). In conclusion, HUI and CHQ
demonstrated construct validity in children undergoing cancer chemotherapy. The Health Utilities Index is subject to a ceiling
effect whereas CHQ requires more time to complete.
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The health-related quality of life (HRQL) of children undergoing
chemotherapy for cancer is becoming increasingly emphasised in
clinical trials. Understanding differences in HRQL associated with
different treatment strategies may be particularly helpful to
families and health-care workers when these strategies are
associated with similar survival.
Some suggest that both generic and disease-specific instruments
should be used in the assessment of HRQL (Guyatt et al, 1993). The
advantage of generic measures is that they provide a rating of
quality of life that permits comparisons across illnesses and often
have normative reference data (Spieth and Harris, 1996). However,
they may lack validity or responsiveness in specialised clinical
subgroups such as children undergoing chemotherapy for cancer.
We have been unable to find a comparison of generic instruments
in this specific group.
We evaluated two questionnaire-based measures of HRQL, the
Health Utilities Index (HUI) and the Child Health Questionnaire
(CHQ). The rationale for choosing these measures is that both the
HUI and CHQ have been used to evaluate survivors of childhood
cancer (Feeny et al, 1992, 1993; Billson and Walker, 1994; Kiltie
and Gattamaneni, 1995; Glaser et al, 1997, 1999a, b; Barr et al 1999;
Sawyer et al, 1999; Speechley et al, 1999; Felder-Puig et al, 2000;
Sands et al, 2001) and they were both incorporated into a cross-
Canada study of the long-term psychosocial and physical health of
childhood cancer survivors (The Late Effects Study) (Gibbons et al,
1994). Additionally, the HUI has been included in every major
Canadian population health survey since, 1990 (Furlong et al,
2001). These questionnaires therefore allow comparison of HRQL
between children receiving cancer chemotherapy and long-term
cancer survivors as well as enabling comparisons to population
estimates of health.
Although HUI and CHQ both measure HRQL, they have
important differences. They are based on different theoretical
approaches with the HUI being a utility-based measure of overall
HRQL, while the CHQ is a health-profile measure using summative
categorical scaling to determine separate scores in two subscales.
Also, different frameworks are used. The HUI uses a narrow
‘within the skin’ approach to the measurement of HRQL and does
not include social interactions (which are considered to reflect
phenomenon other than the strict health of the individual) (Feeny
et al, 1996). Conversely, the CHQ is broader in scope and
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and the impact of the child’s health on behaviour.
There are three studies supporting the validity of the HUI in
children receiving cancer chemotherapy. (Feeny et al, 1992; Barr
et al, 1997; Trudel et al, 1998). These showed that the HUI was able
to discriminate between children on and off treatment for cancer
and was responsive to different phases of treatment in children
receiving maintenance therapy for acute lymphoblastic leukaemia
(ALL). The CHQ has not been studied in this population and
consequently, this is the first study that concurrently examines
both measures in children receiving chemotherapy for cancer.
Our primary objective was to examine the construct validity of
the HUI and CHQ by (1) anticipating that domains within each
instrument that are measuring similar concepts should be
moderately correlated and (2) predicting that the HUI and the
CHQ summary scores should show fair correlation with a global
HRQL visual analogue scale (VAS). Our second objective was to
examine the feasibility and ease of administration of these
instruments.
METHODS
Subjects
This study was part of a larger study examining the measurement
of HRQL in children with a variety of illnesses. The sample for the
study reported here consisted of consecutive children aged
between 1 and 18 years admitted to the Hospital for Sick Children
for cancer chemotherapy. We did not want the acute effects of
chemotherapy to influence the assessment of HRQL strongly;
therefore, we collected data prior to the initiation of chemotherapy
whenever possible and only included those subjects for whom data
could be collected within 24h of chemotherapy initiation. We
excluded children admitted for their first cycle of chemotherapy,
those receiving palliative chemotherapy and those where the
respondent was non-English speaking.
Study design
This study was approved by the Research Ethics Board at the
Hospital for Sick Children and written consent was obtained from
all participating families; children aged between 7 and 15 years
gave verbal assent.
All study questionnaires were administered in an interview
format by one of four trained research assistants. To ensure
consistency in interviewing styles, these four initially piloted the
questionnaires on each other and then working in pairs, performed
12 pilot interviews in which one research assistant administered
the questionnaires and the other observed. Standardised scripts
were used.
Parent report was used for all measurements. The parents were
presented with the different HRQL measures in random order to
control for an order effect at the group level of analysis. The HUI
and VAS both used a 1-week recall period (the period of time that
parents were asked to consider when rating different aspects of
health), while the CHQ was only available with a 4-week recall
period.
Instruments
Health Utilities Index The HUI is a family of multiattribute
health status classification systems which currently consists of two
complementary systems: HUI Mark 2 (HUI2) and HUI Mark 3
(HUI3). (Furlong et al, 2001). The HUI2 was developed to assess
the health status of childhood cancer survivors (Feeny et al, 1992)
and is composed of seven attributes: sensation, mobility, emotion,
cognition, self-care, pain and fertility. Health Utilities Index Mark
3 was first used in the 1990 Ontario Population Health Survey and
it is composed of eight attributes: vision, hearing, speech,
ambulation, dexterity, emotion, cognition and pain. HUI2
describes 24000 unique health states, while HUI3 describes
972000 unique health states.
One of the attractive features of the HUI is that the health states
defined by a comprehensive set of HUI levels can be used to
determine single-attribute and overall utility scores. Utility can be
defined as the strength of an individual’s preference for a health
state measured under conditions of uncertainty and is expressed
on a continuous scale from 0 to 1 in which 0 represents death and 1
represents perfect health (Von Neumann and Morgenstern, 1953).
Utility may be the best measure of HRQL for the purpose of
decision or economic analyses since this measure incorporates the
uncertainty and risk reflected in actual decision-making (Torrance
et al, 2001). The functions for determining HUI utility scores have
been published, and are based on preference measurements from
adults in Hamilton, Ontario. (Torrance et al, 1996; Feeny et al,
2002).
This study used a standard 41-item English-language HUI
s
questionnaire for interviewer administration and proxy respon-
dents (HUI23PIE.40Q). ‘Don’t know’ and ‘refused’ responses were
coded as missing, thus resulting in fewer respondents for whom
there were complete data for HUI compared with other instru-
ments.
Child Health Questionnaire The CHQ is a multidimensional
pediatric-specific HRQL comprehensive measure that encom-
passes 14 health concepts (Landgraf et al, 1996). These health
concepts include physical functioning, bodily pain, general
behaviour, mental health, self-esteem, general health perception
and change in health and family cohesion. Other concepts are the
impact of the illness on the emotional, behavioural and physical
health of the child and the impact of the child’s illness on the
emotional health of the parent, on the activities of the family and
on the time the parent has for personal issues.
The questionnaire responses can be used to generate two
summary scores, the physical health (CHQ PhS) and psychosocial
health (CHQ PsS) subscales. These scores are transformed such
that in a general US population, they have a mean of 50 and a
standard deviation of 10. We used the self-administered 50-item
parent report version (PF-50).
Visual Analogue Scale Respondents were asked to mark the
HRQL of their child on a horizontal 10cm line anchored at one end
by death (score of 0) and the other end by perfect health (score of
1). There were no other increments marked on the line. Perfect
health was described as meaning happiness and the ability to do
the things one likes without pain or illness.
Determination of construct validity
A valid instrument measures what it is purported to measure. In
general, there are two ways that validity is assessed: criterion
validity, in which the measure is compared against a ‘gold
standard’ and construct validity, in which expectations about how
a measure should behave are hypothesised and tested (Guyatt,
1999). Owing to the absence of a gold standard in the measurement
of HRQL, these types of measures are usually assessed by construct
validity.
One of the early steps in construct validation is to hypothesise
how different measures should relate (convergent construct
validity). The more an instrument behaves according to a priori
hypothesised relations, the stronger is the evidence for validity
(Guyatt, 1999).
We examined construct validity in two ways. First, we assessed
a priori expected relation between CHQ health concepts and HUI
single-attribute utilities according to Speechley et al (1999) who
hypothesised the following in a group of childhood cancer
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pain should be 40.50, (b) correlations between CHQ physical
functioning and HUI2 mobility and HUI3 ambulation should be
0.35–0.50, (c) correlations between CHQ mental health and HUI2
and HUI3 emotion should be 0.35–0.50 and (d) correlations
between CHQ general health perception and HUI2 and HUI3
global utilities should be 0.20–0.34. In that study of childhood
cancer survivors, Speechley et al (1999) demonstrated relation that
were similar or stronger than those hypothesised. A second study
found similar relations in a predominantly healthy group of school
children. (Raat et al, 2002).
The second way in which construct validity was assessed was by
anticipating that HUI overall utility scores and CHQ summary
scores should show fair correlation with the VAS described above.
The correlations between scores should be positive since better
health should score higher on all instruments. However, these
correlations should not be strong because the weighting of
different attributes of HRQL is predefined in the HUI and CHQ,
whereas this weighting is subjectively performed by each
respondent in the VAS.
Assessment of ease of use
Respondents were asked to rate ease of use of each questionnaire
on a 5-point categorical scale ranging from very easy to very hard.
The start and stop times for completing each of the instruments
were also recorded.
Analysis
The scores were summarised by instrument using median value
and interquartile range (IQR) because the scores were not
normally distributed. Spearman correlations were used to evaluate
the association between measures. Correlation coefficients were
defined as follows: 0–0.25, negligible or not correlated; 0.25–0.50,
fair correlation; 0.50–0.75, moderate-to-good correlation and
40.75, very good-to-excellent correlation (Colton, 1974).
The difference in the mean times to complete the HUI and CHQ
was assessed using the paired Student’s t-test. Statistical sig-
nificance was defined as Po0.05 and multiple testing was
addressed using Bonferroni adjustment where appropriate. All
analyses were performed using the SAS statistical program (SAS-
PC, Version 8.0; SAS Institute Inc., Cary, NC, USA).
RESULTS
During the period from 1 June 2001 to 1 September 2001, we
identified 42 eligible children. The parents of five refused and one
parent did not complete the study because her child was
interrupted by a diagnostic procedure. In total, 36 parents
completed all the questionnaires. The mean parent respondent
age was 37.7 (s.d.¼5.6) years, while the mean age of their affected
children was 7.2 (s.d.¼4.0) years. Table 1 shows the frequency of
the diagnoses for these children: ALL was the most common
diagnosis occurring in 12 (33%) of the children. The median time
from the diagnosis of cancer to the interview date was 122.5 days
(IQR 72.0, 247.5 days).
The median number of days between administration of the most
recent cycle and the current cycle of chemotherapy was 28 days
(IQR 22.5, 32 days). For the current chemotherapy admission, the
number of hours of chemotherapy received prior to questionnaire
administration was recorded; if chemotherapy had not yet begun
at the administration of the questionnaire, this value was recorded
as 0. The median time on chemotherapy at questionnaire
commencement was 12.4h (IQR 0.1, 20.8h).
Table 2 reports the median scores and the frequency of
minimum and maximum scores for each instrument including
the individual CHQ concepts and HUI single-attribute utilities.
The maximum possible score (ceiling effect) was common with the
HUI but was not seen with the CHQ summary scores.
Table 3 presents the correlations between selected subscale
scores of CHQ and single-attribute utilities of HUI. As anticipated,
CHQ body pain was moderately correlated with HUI3 pain
(r¼0.51; P¼0.001), CHQ physical functioning was moderately
Table 1 Cancer diagnoses
Diagnoses Frequency (percent)
Acute lymphoblastic leukaemia 12 (33.3)
Ewing’s sarcoma 4 (11.1)
Germ cell tumour 3 (8.3)
Wilms tumour 1 (2.8)
Brain tumour 2 (5.6)
Lymphoma 2 (5.6)
Neuroblastoma 6 (16.7)
Osteosarcoma 1 (2.8)
Rhabdomyosarcoma 4 (11.1)
Adrenocortical carcinoma 1 (2.8)
Table 2 Distribution of summary scores
Maximum Minimum
Measure (n) Median (IQR) No. (%) No. (%)
Summary scores
CHQ PsS (36) 46 (39, 52) 0 0
CHQ PhS (36) 34 (21, 45) 0 0
HUI2 (32) 0.93 (0.80, 1.00) 11 (34) 0
HUI3 (32) 0.93 (0.76, 1.00) 15 (47) 0
VAS (35) 0.76 (0.58, 0.84) 0 0
CHQ Concepts
Single-item general health (36) 60 (30,85) 5 (14) 4 (11)
General health perception (36) 52 (43, 66) 0 0
Physical functioning (36) 75 (50, 92) 7 (19) 0
Bodily pain (36) 60 (40, 80) 5 (14) 0
Single-item global behaviour (36) 85 (60,100) 11 (31) 1 (3)
General behavior (36) 77 (65, 86) 2 (6) 0
Mental health (36) 73 (65, 80) 1 (3) 0
Self-esteem (36) 75 (56, 85) 2 (6) 0
Family activities (36) 50 (25, 67) 0 0
Family cohesion (36) 85 (85, 85) 6 (17) 0
Parent time impact (36) 56 (33, 67) 2 (6) 3 (8)
Parent impact emotional (36) 42 (25, 50) 1 (3) 5 (14)
Role–physical (36) 67 (33, 100) 10 (28) 5 (14)
Role–emotional/behaviour (36) 100 (67, 100) 20 (56) 0
HUI2 single-attribute utilities
Sensation (34) 1 (1, 1) 28 (82) 0
Mobility (35) 1 (1, 1) 29 (83) 0
Emotion (36) 1 (0.86, 1) 20 (56) 3 (8)
Cognition (34) 1 (0.86, 1) 25 (74) 0
Self-care (35) 1 (1, 1) 34 (97) 1 (3)
Pain (36) 1 (0.95, 1) 25 (69) 0
HUI3 single-attribute utilities
Vision (35) 1 (1, 1) 33 (94) 0
Hearing (36) 1 (1, 1) 36 (100) 0
Speech (35) 1 (1, 1) 31 (89) 0
Ambulation (35) 1 (1, 1) 32 (91) 0
Dexterity (36) 1 (1, 1) 35 (97) 0
Emotion (36) 1 (1, 1) 31 (86) 0
Cognition (34) 1 (0.92, 1) 25 (74) 0
Pain (36) 1 (0.92, 1) 25 (69) 0
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mental health was moderately correlated with HUI2 emotion
(r¼0.53; P¼0.001). If adjustment for multiple testing had not
been conducted, all correlation coefficients in Table 3 would have
been statistically significant (Po0.05) except for the correlation
between CHQ general health perception and the HUI2 summary
score. In comparing HUI and CHQ summary measures, HUI2 and
HUI3 overall multi-attribute scores were both moderately corre-
lated with CHQ PhS (r¼0.55, P¼0.001 and r¼0.50, P¼0.004
respectively) but were not significantly correlated with PsS
(r¼0.32 and r¼0.09, both P¼NS).
Table 4 presents the relations between HUI and CHQ summary
scores and the HRQL VAS. HUI2 and HUI3 were not correlated
with VAS as illustrated in Figure 1 (for HUI2). We were unable to
fit the data using nonlinear transformations. Conversely, PsS
showed fair correlation with VAS (r¼0.44, P¼0.008); this
relationship is demonstrated in Figure 2.
In trying to determine whether the child’s age influenced the
above findings, construct validation was repeated for the 24
children who were 5 years of age or greater. The findings were
unchanged.
Figure 3 illustrates the ease of completion for all instruments.
The HUI and CHQ were easy to complete with 32 out of 36 (89%)
of parents stating that the questionnaires were easy or very easy.
Completion time was significantly shorter for the HUI (mean¼3.1,
s.d.¼1min) compared to the CHQ (mean¼13.1, s.d.¼3.4min,
Po0.0001).
Table 3 Convergent validity of CHQ and HUI
CHQ concept
HUI2 attribute and correlation
coefficient observed
HUI3 attribute and correlation
coefficient observed
Correlation coefficient
predicted
a
Bodily pain Pain, 0.50* (0.21, 0.71) Pain, 0.51* (0.22, 0.72) 40.50
Physical functioning Mobility, 0.58* (0.31, 0.77) Ambulation, 0.43 (0.12, 0.67) 0.35 – 0.50
Mental health Emotion, 0.53* (0.24, 0.73) Emotion, 0.37 (0.04, 0.62) 0.35 – 0.50
General health perceptions Global HUI2, 0.29 ( 0.06, 0.58) Global HUI3, 0.36 (0.01, 0.63) 0.20 – 0.34
aSpearman correlation coefficients (95% confidence intervals). Criteria adapted from Speechley et al (1999). * P-values o 0.006 (Bonferroni adjustment for multiple testing).
Table 4 Correlation coefficients between HUI and CHQ summary
scores with VAS
a
HUI2 HUI3 CHQ PhS CHQ PsS
VAS 0.04 0.01 0.32 0.44*
( 0.32, 0.39) ( 0.34, 0.37) ( 0.02, 0.59) (0.13, 0.68)
aSpearman correlation coefficients (95% confidence intervals). *Po0.01 (Bonferroni
adjustment for multiple testing).
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Figure 1 Scatterplot of HUI2 and VAS. The y-axis represents the scores
on the HUI2 where 0 represents HRQL equal to death and 1 represents
HRQL equal to perfect health. The x-axis represents the scores on the
global HRQL VAS with the same anchors.
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Figure 2 Scatterplot of CHQ PsS and VAS. The y-axis represents the
scores on the CHQ PsS in which higher scores reflect better HRQL. The x-
axis represents the scores on the global HRQL VAS in which 0 is equal to
death and 1 is equal to perfect health. The line represents the least-squares
regression line.
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Figure 3 Bar graph illustrating the ease of completion of the different
measures using a 5-point categorical scale. No-one rated any instrument as
‘difficult’ or ‘very difficult’ to complete.
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In this study, we have shown that CHQ and HUI demonstrate
construct validity in children undergoing chemotherapy as the
CHQ health concepts and HUI single-attribute utility scores were
related according to a priori expectations. However, while the CHQ
PsS subscale was significantly correlated with VAS, HUI was not
correlated with VAS. There are at least two possible reasons why
CHQ and HUI may have different relation with VAS. First, both
CHQ and VAS measure phenomena ‘outside the skin’ and thus,
may be measuring a more ‘global’ construct of health compared to
HUI. Second, disparity in HUI and VAS may arise because HUI
utilities reflect mean community preferences about a health state
defined by a well-specified classification system. In contrast, VAS
reflects a parent’s opinion about their particular child’s subjec-
tively defined health state that may not be definable in terms of an
HUI system.
We have also demonstrated that it is feasible to recruit parents
as proxy respondents and obtain data on HRQL while children are
receiving chemotherapy for cancer. Consequently, this study has
important implications regarding the incorporation of HRQL
measures in clinical trials within paediatric oncology. Parents are
an important source of HRQL measurement in pediatric cancer
trials as many of the affected children are too young for self-
reporting. However, when parents are the respondents, it is
possible that factors such as the emotional state and health of the
parent can affect their assessment of their child’s HRQL.
In deciding which measure should be incorporated into a
clinical trial, several factors should be considered. The advantages
of the HUI are that it is simple to use and requires little time to
complete. The CHQ is similarly easy to use and is not subject to a
ceiling effect, although it does require more time. The Health
Utilities Index is preferable for the purposes of decision or
economic analyses because of the expression of HRQL as a utility.
The HUI may also be preferable if the purpose of the trial is to
capture elements of HRQL that are restricted to ‘within the skin’
phenomena. However, if a more global measure of HRQL is
preferred, then CHQ may be better.
The HUI may be problematic if incorporated into a trial
attempting to improve the HRQL of children receiving an intensity
of chemotherapy similar to our cohort because of its ceiling effect.
We hypothesised that the HRQL of children receiving such
chemotherapy is likely diminished between chemotherapy cycles
related to common toxicities of treatment such as fatigue, fever
and mucositis in addition to the emotional burden of having a life-
threatening diagnosis; despite this many of the children had
perfect HRQL according to HUI.
Our conclusions must be considered in the light of at least three
limitations. First, although our study does represent the largest
study evaluating either the HUI or CHQ in children receiving
cancer chemotherapy, the sample size was small. While the
correlation between CHQ physical functioning and HUI3 ambula-
tion, and the correlation between CHQ mental health and HUI3
emotion were within the predicted ranges, the correlations were
not statistically significant after adjustment for multiple testing,
most likely related to insufficient statistical power. However, we
did see a wide variety of different HRQL experiences in our study
and were able to show several statistically significant correlations
between the measures, suggesting that our sample size was
adequate for our purposes.
The second limitation was the age of the children included in
this study; 33% were less than 5 years old, reflecting the age
distribution of children admitted for cancer chemotherapy. Both
the HUI and CHQ are recommended for children of age greater
than 5 years (Landgraf et al, 1996; Furlong et al, 2001). However,
two of the studies examining the HUI in children undergoing
anticancer therapy included children under the age of 5 years (Barr
et al, 1997; Trudel et al, 1998); and specifically, the report by Barr
et al (1997) included children as young as 11 months with a
median age of 3 years 11 months. Both studies demonstrated that
the HUI was reliable and valid in this population and age range.
Furthermore, the robustness of our findings when the analysis was
limited to those greater than 5 years of age further suggests that
our results are valid even though young children were included.
Nonetheless, our results must be cautiously interpreted in light of
the age of our population.
Finally, the recall period for CHQ and HUI differed, as the CHQ
was only available with a 4-week recall period. While we were
reassured that the correlation between domains fell within the
expected ranges, it is possible that there were real differences
between the children’s HRQL during the past week compared to
the past 4 weeks. Validation of the CHQ with a 1-week recall period
or validation of the HUI with a 4-week recall period in children
undergoing cancer chemotherapy may be useful.
In summary, in children undergoing chemotherapy for cancer,
HUI and CHQ demonstrate construct validity and either measure
is appropriate to use in studies of HRQL. Both are easy to use
although the HUI is subject to a ceiling effect while CHQ requires
more time.
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